The rapid emergence of a new, highly lethal synthetic drug epidemic is outpacing traditional law enforcement strategies. Unlike historical narcotics, these synthetic substances are easily manufactured, endlessly alterable, and increasingly potent, with over 1,450 new psychoactive variants currently identified. Prisons have become primary testing grounds for these drugs, where traffickers smuggle substances by soaking paper in liquid chemicals to bypass security. New York Times reporter Azam Ahmed highlights how supply-side interventions—such as targeting kingpins or restricting precursor chemicals—consistently fail because the market rapidly innovates in response to regulation. This cycle of enforcement proves ineffective, suggesting that addressing the crisis requires moving beyond punitive measures toward public health-oriented harm reduction strategies, such as universal access to overdose-reversal tools, to mitigate the rising death toll.
Sign in to continue reading, translating and more.
Open full episode in Podwise